Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0
|
作者：
Rosas, I. [1 ]
Solomon, J. [2 ]
Donoff, S. [3 ]
Woodhead, F. [4 ]
Raghu, G. [5 ]
Hilary, G. [6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Univ Leicester, Leicester, Leics, England
[5] Univ Washington, Seattle, WA 98195 USA
[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[7] TRAIL NETWORK, Seattle, WA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4534
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4534
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2 STUDY OF SAFETY, TOLERABILITY, AND EFFICACY OF PIRFENIDONE IN PATIENTS WITH RHEUMATOID ARTHRITIS INTERSTITIAL LUNG DISEASE
    Solomon, J.
    WOODHEAD, F.
    DANOFF, S.
    HAYNES-HARP, S.
    NAIK, T.
    SPINO, C.
    HURWITZ, S.
    MAURER, R.
    CHAMBERS, D.
    KOLB, M.
    GOLDBERG, H.
    ROSAS, I.
    CHEST, 2022, 161 (06) : 262A - 262A
  • [2] A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
    Solomon, Joshua
    Woodhead, Felix
    Danoff, Sonye
    Haynes-Harp, Shana
    Naik, Tanvi
    Spino, Cathie
    Hurwitz, Shelley
    Maurer, Rie
    Chambers, Daniel
    Kolb, Martin
    Goldberg, Hiliary
    Rosas, Ivan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4105 - 4108
  • [3] Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
    Solomon, Joshua J.
    Danoff, Sonye K.
    Woodhead, Felix A.
    Hurwitz, Shelley
    Maurer, Rie
    Glaspole, Ian
    Dellaripa, Paul F.
    Gooptu, Bibek
    Vassallo, Robert
    Cox, P. Gerard
    Flaherty, Kevin R.
    Adamali, Huzaifa, I
    Gibbons, Michael A.
    Troy, Lauren
    Forrest, Ian A.
    Lasky, Joseph A.
    Spencer, Lisa G.
    Golden, Jeffrey
    Scholand, Mary Beth
    Chaudhuri, Nazia
    Perrella, Mark A.
    Lynch, David A.
    Chambers, Daniel C.
    Kolb, Martin
    Spino, Cathie
    Raghu, Ganesh
    Goldberg, Hilary J.
    Rosas, Ivan
    LANCET RESPIRATORY MEDICINE, 2023, 11 (01): : 87 - 96
  • [4] EFFICACY AND TOLERABILITY OF A HOMEOPATHIC MEDICATION INCENA IN PATIENTS WITH RHEUMATOID ARTHRITIS (RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY)
    Iaremenko, O.
    Mykytenko, G.
    Iaremenko, K.
    Matiyaschuk, I.
    Ivashkivsky, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 963 - 964
  • [5] Efficacy and Safety of Ketoprofen Patch in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study
    Kawai, Shinichi
    Uchida, Eiji
    Kondo, Masakazu
    Ohno, Syuji
    Obata, Junichi
    Nawata, Yasushi
    Sugimoto, Kazunori
    Oribe, Motohiro
    Nagaya, Ikuo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (10): : 1171 - 1179
  • [6] A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases
    Weisman, Michael H.
    Paulus, Harold E.
    Burch, Francis X.
    Kivitz, Alan J.
    Fierer, Joshua
    Dunn, Meleana
    Kerr, David R.
    Tsuji, Wayne
    Baumgartner, Scott W.
    RHEUMATOLOGY, 2007, 46 (07) : 1122 - 1125
  • [7] A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis
    Pineda, Maria de los Angeles
    Thompson, Sarah Frances
    Summers, Kelly
    de Leon, Faye
    Pope, Janet
    Reid, Gregor
    MEDICAL SCIENCE MONITOR, 2011, 17 (06): : CR347 - CR354
  • [8] Efficacy and Safety of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): The Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2a IRIS-RA Study
    Taylor, Peter C.
    Schett, Georg
    Ibrahim, Fowzia
    Zhou, Bei
    Leu, Jocelyn H.
    Liva, Sophia G.
    Wang, Qingmin
    Cella, Ricardo Rojo
    Karyekar, Chetan S.
    Fei, Kaiyin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1682 - 1684
  • [9] Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
    Stohl, William
    Merrill, Joan T.
    McKay, James D.
    Lisse, Jeffrey R.
    Zhong, Z. John
    Freimuth, William W.
    Genovese, Mark C.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 579 - 589
  • [10] SAFETY AND EFFICACY OF SBI-087 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Damjanov, N.
    Tlustochowicz, M.
    Aelion, J.
    Dimic, A.
    Greenwald, M.
    Diehl, A.
    Bhattacharya, I.
    Menon, S.
    Gourley, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 61
12345